Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients (Q44411974)

2 December 2017

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients (English)

1 reference

2 December 2017

0 references

1 reference

5

1 reference

2 December 2017

J M Iwasenko

1

1 reference

2 December 2017

G M Scott

series ordinal

2

1 reference

2 December 2017

Z Naing

series ordinal

3

1 reference

2 December 2017

A R Glanville

series ordinal

4

1 reference

2 December 2017

10 November 2010

1 reference

Transplant Infectious Disease

2 December 2017

1 reference

2 December 2017

13

1 reference

2 December 2017

2

1 reference

2 December 2017

145-153

1 reference

Investigation of CMV disease in immunocompromised patients

2 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

The case for cytomegalovirus prophylaxis in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Antiviral drug resistance in human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2010.00584.X

10.1111/J.1399-3062.2010.00584.X

21 January 2018

Identifiers

DOI

1 reference

release_wdiks5vcizgpzf6v3kz4d56hqi

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wdiks5vcizgpzf6v3kz4d56hqi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference